Stroke-Like Episodes in PMM2-CDG: When the Lack of Other Evidence Is the Only Evidence. [PDF]
Serrano M.
europepmc +1 more source
Non-functional alternative splicing caused by a Latino pathogenic variant in a case of PMM2-CDG. [PDF]
González-Domínguez CA +16 more
europepmc +1 more source
Stress-induced secretory pathway disruption causes atypical metalloproteinase transport in PMM2-CDG. [PDF]
Wu CL +6 more
europepmc +1 more source
Investigation of the Clinical and Genetic Spectrum of PMM2-CDG: Insights from a Family with a Novel Variant and Previous Studies. [PDF]
Alagha P +6 more
europepmc +1 more source
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG. [PDF]
Zhong ML, Lai K.
europepmc +1 more source
Stroke-like episodes (SLE) occur in phosphomannomutase deficiency (PMM2-CDG), and may complicate the course of channelopathies related to Familial Hemiplegic Migraine (FHM) caused by mutations in CACNA1A (encoding CaV2.1 channel).
Martínez Monseny, Antonio Federico +19 more
core
Integrated glycoproteomics reveals site-specific N-glycosylation defects in phosphomannomutase two congenital disorder of glycosylation. [PDF]
Nilsson J +6 more
europepmc +1 more source
Glycosylation disorders in pediatric epilepsy: pathophysiology, imaging and precision therapy. [PDF]
Fan L, Shen Y, Wang J, Gan J.
europepmc +1 more source

